KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 5.03.

  • Emergent BioSolutions' Interest Coverage Ratio fell 3523.56% to 5.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.99, marking a year-over-year increase of 20867.59%. This contributed to the annual value of 1.53 for FY2024, which is 8147.39% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Interest Coverage Ratio stood at 5.03, which was down 3523.56% from 0.11 recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Interest Coverage Ratio high stood at 31.87 for Q4 2021, and its period low was 12.29 during Q3 2023.
  • In the last 5 years, Emergent BioSolutions' Interest Coverage Ratio had a median value of 0.64 in 2024 and averaged 0.24.
  • Per our database at Business Quant, Emergent BioSolutions' Interest Coverage Ratio soared by 90417.85% in 2021 and then plummeted by 128486.82% in 2022.
  • Emergent BioSolutions' Interest Coverage Ratio (Quarter) stood at 31.87 in 2021, then crashed by 113.56% to 4.32 in 2022, then surged by 53.28% to 2.02 in 2023, then soared by 68.2% to 0.64 in 2024, then soared by 884.07% to 5.03 in 2025.
  • Its last three reported values are 5.03 in Q3 2025, 0.11 for Q2 2025, and 3.39 during Q1 2025.